Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAS181 for Parainfluenza in Immunocompromised Patients
NCT01644877Phase 2Completed
- Sponsor
- Ansun Biopharma
- Start
- Mar 2014
- Primary completion
- Dec 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of DAS181 in parainfluenza virus infection, sponsored by Ansun Biopharma. Started Mar 2014; status: completed.
02
Drugs
DAS181
03
Conditions
parainfluenza virus infection
Beyond the preview
Go deeper on NCT01644877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01644877.